Literature DB >> 8870406

Factors affecting production of haemolysin by strains of Vibrio fluvialis.

Z Rahim1, K M Aziz.   

Abstract

The in vitro production of haemolysin by Vibrio fluvialis was studied using sheep erythrocyte. The effect of the composition of various media and different concentrations of sodium chloride on the production of haemolysin and heat-stability was investigated. Comparatively higher titre of haemolysin production was noted in brain heart infusion (BHI) broth. Adding 0.5% NaCl to BHI broth reduced the production of haemolysin; adding 5.0% NaCl to the medium totally inhibited it. The highest titre of haemolysin was produced at 30 degrees C and 37 degrees C, whereas no haemolysin was produced at 50 degrees C. Haemolytic activity was totally destroyed when heated at 56 degrees C for 30 minutes. Haemolysin could be assayed easily following this method.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870406

Source DB:  PubMed          Journal:  J Diarrhoeal Dis Res        ISSN: 0253-8768


  4 in total

1.  Laboratory indicators for early detection and surgical treatment of vibrio necrotizing fasciitis.

Authors:  Yao-Hung Tsai; Robert Wen-Wei Hsu; Kuo-Chin Huang; Tsung-Jen Huang
Journal:  Clin Orthop Relat Res       Date:  2010-03-16       Impact factor: 4.176

Review 2.  Vibrio fluvialis: an unusual enteric pathogen of increasing public health concern.

Authors:  Etinosa O Igbinosa; Anthony I Okoh
Journal:  Int J Environ Res Public Health       Date:  2010-10-12       Impact factor: 3.390

3.  Purification and characterization of enterotoxigenic El Tor-like hemolysin produced by Vibrio fluvialis.

Authors:  Mahendra H Kothary; Heather Lowman; Barbara A McCardell; Ben D Tall
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

4.  The virulence phenotypes and molecular epidemiological characteristics of Vibrio fluvialis in China.

Authors:  Pu Liang; Xiaoying Cui; Xiaoli Du; Biao Kan; Weili Liang
Journal:  Gut Pathog       Date:  2013-03-22       Impact factor: 4.181

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.